At. Melton et al., PROLONGED DURATION OF SUCCINYLCHOLINE IN PATIENTS RECEIVING ANTICONVULSANTS - EVIDENCE FOR MILD UP-REGULATION OF ACETYLCHOLINE-RECEPTORS, Canadian journal of anaesthesia, 40(10), 1993, pp. 939-942
Succinylcholine (SCh) normally causes a small increase in serum potass
ium concentration, but certain conditions may predispose to severe hyp
erkalaemia. This is due to ''up-regulation'' of skeletal muscle acetyl
choline receptors (AChR), which also results in resistance to non-depo
larizing muscle relaxants (NDMR). Anticonvulsant therapy causes NDMR r
esistance because of sub-clinical blockade, and diminished release, of
acetylcholine. We studied nine patients chronically receiving anticon
vulsants (phenytoin and/or carbamazepine) and nine control patients. A
naesthesia was induced typically with thiopentone or propofol, isoflur
ane and N2O were used for maintenance. The ulnar nerve was supramaxima
lly stimulated and mechanical twitch height was measured with a force
transducer al the adductor pollicis, before and after SCh 1 mg . kg-1,
until return to baseline height. Plasma potassium concentration was m
easured before and at three, five, and ten minutes following SCh. Mean
maximum potassium rise was 0.2 mEq . L-1 in each group. The time for
return to baseline twitch height was 14.3 +/- 2.3 min (mean +/- SD) in
the anticonvulsant group and 10.0 +/- 1.6 min in the control group, P
= 0.001. The recovery index (time for 25% to 75% recovery) was 2.6 +/
- 0.9 min in the anticonvulsant group and 1.4 +/- 0.3 min in the contr
ol group, P < 0.01. The normal potassium response coupled with prolong
ed duration suggests a hypersensitivity to SCh that is consistent with
an anticonvulsant-induced mild upregulation of AChR.